Vimarsana
Biggest News Aggregation in the World

Page 3 - Cell Gene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Gene Today - Breaking & Trending Today

Supporting Multiple Global Gene Therapy Studies For Rare Diseases - Vimarsana News

Supporting Multiple Global Gene Therapy Studies For Rare Diseases

Supporting Multiple Global Gene Therapy Studies For Rare Diseases A long-term client called upon the Veristat team for help conducting two investigational Phase I/II studies. These global studies focused on proving the safety and efficacy of gene therapy for two rare genetic disorders. Working side-by-side with the client, our cell and gene therapy experts addressed many complicated challenges – including site start-up issues, stringent regulatory requirements, and the logistics of handling highly sensitive genetic material. Study Demographics Primary Services Provided: Signing up provides ...

Global Leukemia Therapeutics Markets, 2016-2020 & 2021-2026 - Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, & Others - Vimarsana News

Global Leukemia Therapeutics Markets, 2016-2020 & 2021-2026 - Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, & Others

Share this article Share this article ResearchAndMarkets.com's offering. The Global Leukemia Therapeutics Market was valued USD18584.23 Million in 2020 and is expected to grow at a CAGR of 7.47% during the forecast period. The Global Leukemia Therapeutics Market is driven by the technological advancements and innovations in the field of blood cancer testing on account of the growing number of patients suffering from leukemia. Additionally, growing awareness among the population pertaining to adoption of preventive healthcare is further expected to propel the market during forecast period. Su...

Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie - Vimarsana News

Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie

Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie Continues to build integrated capabilities platform for Cell Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited ("The ABL site") in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions. The ABL site con...

Worldwide Industry for CAR-T Cell Therapy (2021 to 2027) - Players Profiled Include Aleta BioTherapeutics, Anixa Biosciences and BioNTech Among Others - Vimarsana News

Worldwide Industry for CAR-T Cell Therapy (2021 to 2027) - Players Profiled Include Aleta BioTherapeutics, Anixa Biosciences and BioNTech Among Others

Share this article Share this article ResearchAndMarkets.com's offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as "living drugs." T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune system and play a key role in directing the immune response and killing cells infected by pathogens....